Home » US Anticoagulation Therapy

Tag: US Anticoagulation Therapy

US Anticoagulation Therapy Market : Increasing prevalence of cardiovascular diseases and blood disorders

Posted on: | By: – Comments Off
US Anticoagulation Therapy Market

The anticoagulation therapy market for PT/INR testing devices is segmented into in-office testing devices and home testing devices. The in-office devices segment dominated the US anticoagulation therapy market for PT/INR testing devices. The large share of this segment is mainly attributed to the large number …

Read More

US Anticoagulation Therapy Market Worth $27.83 Billion by 2022 : CAGR of 8.5%

Posted on: | By: – Comments Off
US Anticoagulation Therapy Market

According to the new market research report by MarketsandMarkets, the US anticoagulation therapy market is projected to reach USD 27.83 Billion by 2022 from USD 17.25 Billion in 2016, at a CAGR of 8.5% US Anticoagulation Therapy Market by Product ((Anticoagulants Drugs (NOACs, Warfarin)), PT/INR Devices (In-Office, …

Read More